|
Donald E. Hricik, MD |
Donald E. Hricik is Professor of Medicine and Chief of the Division of Nephrology at Case Western Reserve University School of Medicine in Cleveland, Ohio, where he also serves as Medical Director of the Transplantation Service at the University Hospitals of Cleveland. Dr. Hricik’s current research interests include approaches to reduce the side effects of immunosuppressive regimens in renal transplantation and immunologic monitoring of renal transplant recipients. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
John Gill, MD, MS Associate Professor of Medicine University of British Columbia Division of Nephrology St. Paul’s Hospital Vancouver, Canada |
Dr. Gill obtained his MD from the University of British Columbia (U.B.C.) in 1995. He completed his specialty training in internal medicine at the University of Western Ontario (1995-1998) and his sub-specialty training in nephrology at U.B.C. He then completed a clinical research fellowship at Tufts-New England Medical Center in Boston, MA. During this time he also completed a Masters degree in clinical outcomes research at Tufts University. He joined the nephrology division at St. Paul’s Hospital, University of British Columbia in July 2002. Dr. Gill is President elect of the Canadian Society of Nephrology, and Immediate President of the Canadian Organ Replacement Register. He is involved in clinical outcomes research in kidney transplant recipients, and is an associate editor of the American Journal of Transplantation. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Anil K. Chandraker, MD, FRCP, FASN Assistant Professor of Medicine, Harvard Medical School Medical Director of Kidney and Pancreas Transplantation Brigham and Women’s Hospital Boston, MA. |
Dr. Chandraker received his Medical Degree from Glasgow University in 1987 and did his Fellowship training in Nephrology/Transplant Immunology at Brigham and Women’s Hospital/Harvard Medical School in Boston, MA. He has received research funding from Juvenile Diabetes Research Foundation, National Kidney Foundation and the National Institutes of Health. His lab based research centers around investigating the role of T cell co-stimulatory pathways in the development of chronic rejection and transplant tolerance. He is the protocol chair on NIH sponsored Clinical Trails in Organ Transplantation. His clinical research interests include understanding the development of the immune response against transplanted organs. His laboratory research is on the role of the T cell in chronic allograft rejection. He has authored over 100 original scientific papers, review article and book chapters and has served on the Editorial Board of several medical journals. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Fernando G. Cosio, MD Medical Director, Kidney-Pancreas Transplant Program Mayo Clinic Transplant Center Rochester, MN.
|
Dr. Cosio received his medical degree from the University of Valladolid, Valladolid, Spain. His internship and residency were in Hennepin County Medical Center, Minneapolis, MN. He received fellowship training in Nephrology with the University of Minnesota Medical School, Minneapolis, MN. His interests include Transplant nephrology, long term care of the kidney transplant patient, and glomerulonephritis. He is certified by the American Board of Internal Medicine in Nephrology and is extensively published in scholarly journals, books and book chapters. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Robert L. Fairchild, PhD Professor of Molecular Medicine Immunology Department of Immunology Cleveland Clinic Lerner Research Institute Cleveland, OH |
Dr. Fairchild is currently Professor of Molecular Medicine in the Lerner Research Institute. Dr. Fairchild’s areas of general research interest are: skin disease, skin, renal and cardiac allograft rejection, T cell recruitment to inflammation in peripheral tissues with special focus on transplantation immunology. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Philip Francis Halloran, MD, PhD, FRCP(C), OC, FRSC Director, Alberta Transplant Applied Genomics Centre Professor, Departments of Medicine and Medical Microbiology & Immunology, University of Alberta, Edmonton, Alberta, Canada |
Dr. Halloran earned his MD in 1968 and his FRCP(C) from the University of Toronto (TGH) in1973 and his PhD from the University of London, England,1976. His post-graduate experience at TGH included Assistant Chief Resident, Medicine, and Nephrology Resident, and Research Assistant, Dept. of Immunology, Middlesex Hospital College, London, England
Dr. Halloran’s principal research interests include: IFN-γ and the mechanisms of T cell-mediated graft rejection. Inflammatory response to injury and its impact on the immune response. The mechanism of action of immunosuppressive drugs. The role of the alloantibody response in clinical transplantation and the relevance of somatic cell senescence mechanisms in the deterioration of organ transplants. He is a member of numerous Grant Panels, University Committees, Professional & Elected Societies, Government and National Committees. Dr. Halloran is a well known international lecturer being invited to address over 350 symposiums, industry, and university groups. He serves on key transplant editorial boards, and is credited with over 600 peer reviewed publications and abstracts |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Peter S. Heeger, MD Director of Transplant Research Renal Division Ricanati Miller Transplant Institute Mount Sinai School of Medicine, New York, NY |
Dr. Heeger received his BA (1980) and MD (1984) degrees from the University of Pennsylvania in Philadelphia, Pa. He completed an Internal Medicine residency and a year as Chief Medical Resident at Temple University Health Sciences Center before returning to the University of Pennsylvania to complete his clinical and research training in the Renal Electrolyte Section. He moved to Cleveland in 1993 as an Assistant Professor of Nephrology at Case Western Reserve University (CWRU) and appointments in the Departments of Nephrology and Urology at CCF and in the Institute of Pathology at CWRU. Dr. Heeger is currently the Director of Transplant Research in the Renal Division at the Ricanati Miller Transplant Institute, Mount Sinai School of Medicine. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Michael G. Ison, MD, MS Assistant Professor Divisions of Infectious Diseases and Organ Transplantation Northwestern University Feinberg School of Medicine Northwestern University Comprehensive Transplant Center Chicago, IL |
Dr. Ison received his BA degree at Grinnell College, 1993 and his medical degree at the University of South Florida College of Medicine, Tampa in 1997, served his residency at Oregon Health Sciences University, Portland, OR, and served his Infectious Diseases fellowship at the University of Virginia, Charlottesville, VA; he received his MS degree during his ID fellowship. He did additional training in Transplant Infectious Diseases in 2005 at Massachusetts General Hospital, Boston, MA . Dr. Ison's clinical and research Interests include respiratory viral infections and transplant-related infections. Additionally, he served as the Chair of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee from 2006 until July 2010. He is Board certified in internal medicine and infectious diseases. Dr. Ison is widely published in numerous scholarly journals and has contributed to several books and book chapters. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Jon Kobashigawa, MD Associate Director, Clinical Affairs, Cedars-Sinai Heart Institute Director, Advanced Heart Disease Director, Heart Transplant Program DSL/Thomas D. Gordon Chair in Heart Transplantation Medicine Cedars-Sinai Medical Center, Los Angeles, CA |
Dr. Kobashigawa, at the Cedars-Sinai Heart Institute, is Associate Director for Clinical Affairs, Director of Advanced Heart Disease and Director of the Heart Transplant Program. In addition, he holds the DSL/Thomas D. Gordon Chair in Heart Transplantation Medicine. He also is a clinical professor of medicine and cardiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He is board certified in internal medicine and cardiovascular disease. After earning his bachelor's at Stanford University, Dr. Kobashigawa earned his medical degree at Mount Sinai School of Medicine in New York. He performed his internship and residency in internal medicine followed by a fellowship in cardiology at the UCLA Medical Center. Dr. Kobashigawa specializes in heart transplantation, advanced heart failure, cardiac catheterization, athletic heart syndrome, sudden cardiac death and valvular heart disease. Dr. Kobashigawa is recognized nationally and internationally as a leader in the heart transplant field. He is a past President of the International Society of Heart and Lung Transplantation, has published over 200 peer reviewed articles, chapters and monographs in the field of heart transplantation and has chaired several multi-center heart transplant studies. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Herwig-Ulf Meier-Kriesche, MD, Professor of Medicine and Medical Director of the Kidney Pancreas Transplant Program at the University of Florida Gainesville, FL |
Dr. Meier-Kriesche received his medical degree from the University of Perugia in Italy, and did his internal medicine training with a subspecialty in nephrology at the University of Cagliari in Italy. He then spent two years as a research fellow in the division of Immunology and Organ Transplantation at the University of Texas in Houston and completed a nephrology fellowship in their Division of Nephrology and a Transplant Nephrology Fellowship at the University of Michigan where he was recruited to remain on faculty. Dr. Meier-Kriesche joined the University of Florida in 2001. He is recognized nationally and internationally for his contributions to the evidence base in transplantation. His research interests include study design, immunosuppressive protocols and outcomes research in transplantation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
